Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, reported financial results for its fiscal first quarter, ended September 30, 2021.
PlatoAi. Web3 Reimagined. Data Intelligence Amplified.
Click here to access.

Source: https://www.biospace.com/article/releases/cardiovascular-systems-inc-reports-fiscal-2022-first-quarter-financial-results/?s=93